Back to Search
Start Over
The Feasibility of 64Cu-PSMA I&T PET for Prostate Cancer
- Source :
- Cancer Biotherapy and Radiopharmaceuticals. 37:417-423
- Publication Year :
- 2022
- Publisher :
- Mary Ann Liebert Inc, 2022.
-
Abstract
- Background: The goal of this article was to investigate the feasibility of 64Cu labeling in prostate-specific membrane antigen imaging and therapy (PSMA I&T) for PSMA positron emission tomography (...
- Subjects :
- Pharmacology
Cancer Research
medicine.diagnostic_test
business.industry
General Medicine
Pet imaging
urologic and male genital diseases
medicine.disease
Prostate cancer
Oncology
Positron emission tomography
Medicine
Radiology, Nuclear Medicine and imaging
business
Nuclear medicine
Membrane antigen
Subjects
Details
- ISSN :
- 15578852 and 10849785
- Volume :
- 37
- Database :
- OpenAIRE
- Journal :
- Cancer Biotherapy and Radiopharmaceuticals
- Accession number :
- edsair.doi...........59a8b0460bf447da8751810b91a3b976